Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
98.47
-3.03 (-2.99%)
At close: Jul 14, 2025, 4:00 PM
98.50
+0.03 (0.03%)
After-hours: Jul 14, 2025, 7:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2014 - 2019 |
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Diagnostics Revenue (Pre-Q3 2022) | 1.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Diagnostics Revenue (Pre-Q3 2022) Growth | 3.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Product Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Product Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Service Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Service Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) | 1.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) Growth | -0.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Product | 2.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Product Growth | -1.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Service | 416.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Service Growth | 23.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Applied Markets Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Applied Markets Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2014 - 2019 |
Other | 36.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 36.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 36.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 36.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income (Pre-Q3 2022) | 373.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income (Pre-Q3 2022) Growth | 15.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Operating Income (Post-Q2 2022) | 448.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Discovery & Analytical Solutions Operating Income (Post-Q2 2022) Growth | -1.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|